These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2960052)

  • 1. Immunosuppressive activity of cyclosporine metabolites in vitro.
    Schlitt HJ; Christians U; Wonigeit K; Sewing KF; Pichlmayr R
    Transplant Proc; 1987 Oct; 19(5):4248-51. PubMed ID: 2960052
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for a cyclosporine-resistant pathway of T cell activation triggered via the CD3/T cell receptor complex.
    Schlitt HJ; Schwinzer R; Kurrle R; Wonigeit K
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):103-9. PubMed ID: 2966472
    [No Abstract]   [Full Text] [Related]  

  • 3. Synergistic effect of the rapamycin-cyclosporine combination: median effect analysis of in vitro immune performances by human T lymphocytes in PHA, CD3, and MLR proliferative and cytotoxicity assays.
    Kahan BD; Gibbons S; Tejpal N; Chou TC; Stepkowski S
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1090-1. PubMed ID: 1824888
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporine inhibits T-cell activation at two distinct levels: role of the CD 28 activation pathway.
    Hess AD; Bright EC
    Transplant Proc; 1991 Feb; 23(1 Pt 2):961-6. PubMed ID: 1846483
    [No Abstract]   [Full Text] [Related]  

  • 5. Different modes of T-cell activation by monoclonal antibodies to the alpha/beta T-cell receptor and the CD3 complex.
    Schlitt HJ; Schwinzer R; Wonigeit K
    Transplant Proc; 1989 Feb; 21(1 Pt 1):147-8. PubMed ID: 2523121
    [No Abstract]   [Full Text] [Related]  

  • 6. The complications of newer transplant antirejection drugs: treatment with cyclosporin A, OKT3, and FK506.
    Li PK; Nicholls MG; Lai KN
    Adverse Drug React Acute Poisoning Rev; 1990; 9(3):123-55. PubMed ID: 1703724
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of FK 506 and cyclosporine on T-cell activation: integrin-mediated adhesion of T cells, proliferation, and maturation of cytotoxic T cells.
    Eiras G; Shimizu Y; van Seventer GA; Duquesnoy RJ; Zeevi A
    Transplant Proc; 1991 Feb; 23(1 Pt 2):936-9. PubMed ID: 1703357
    [No Abstract]   [Full Text] [Related]  

  • 8. Two-signal model for T-cell activation: molecular mechanisms.
    Sehajpal PK; Sharma VK; Stenzel KH; Suthanthiran M
    Transplant Proc; 1993 Feb; 25(1 Pt 1):104-5. PubMed ID: 8094907
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the in vitro immunosuppressive effects of cyclosporine A and its metabolites.
    Copeland KR; Yatscoff RW; Rush D; Jeffery JR
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1449-52. PubMed ID: 2523585
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of anti-CD3 (T3) antibody-induced activation of T cells by cyclosporine.
    Bentin J; Carson DA; Vaughan JH; Tsoukas CD
    Transplantation; 1986 Sep; 42(3):317-20. PubMed ID: 3092413
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of cyclosporin A on human lymphocyte responses in vitro. V. Analysis of responding T lymphocyte subpopulations in primary MLR with monoclonal antibodies.
    Hess AD; Donnenberg AD; Tutschka PJ; Santos GW
    J Immunol; 1983 Feb; 130(2):717-21. PubMed ID: 6217251
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mechanism of action of cyclosporin A].
    Wagner H; Hardt C; Heeg K
    Internist (Berl); 1985 Sep; 26(9):530-3. PubMed ID: 2933358
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the biologic activities of Sandimmun metabolites in humans and in animal models: review and original experiments.
    Fahr A; Hiestand P; Ryffel B
    Transplant Proc; 1990 Jun; 22(3):1116-24. PubMed ID: 2140916
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of human T-cell activation by FK 506, rapamycin, and cyclosporine A.
    Sigal NH; Lin CS; Siekierka JJ
    Transplant Proc; 1991 Apr; 23(2 Suppl 2):1-5. PubMed ID: 1712132
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of cyclosporine metabolites M17 and M18 on proliferation and interleukin 2 production in the mixed lymphocyte culture.
    Freed BM; Rosano TG; Quick C; Lempert N
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1223-6. PubMed ID: 2950629
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined immunosuppressive effect of FK 506 and other immunosuppressive agents on PHA- and CD3-stimulated human lymphocyte proliferation in vitro.
    Jiang H; Suguo H; Takahara S; Takano Y; Li D; Kameoka H; Moutabarrik A; Kokado Y; Ishibashi M; Okuyama A
    Transplant Proc; 1991 Dec; 23(6):2933-6. PubMed ID: 1721317
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of FK 506 and low concentration cyclosporine on human lymphocyte activation antigen expression: a flow cytometric analysis.
    Woo J; Sewell HF; Thomson AW
    Transplant Proc; 1990 Aug; 22(4):1645-6. PubMed ID: 1697113
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of prednisolone and cyclosporin A on monocyte-dependent and -independent human T-cell proliferation in vitro.
    Bloemena E; van Lier RA; van Oers MH; Weinreich S; Stilma-Meinesz AP; Schellekens PT
    Transplant Proc; 1989 Feb; 21(1 Pt 1):861-5. PubMed ID: 2784907
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of cyclosporine A on T lymphocytes and accessory cells from human blood.
    Granelli-Piperno A; Keane M
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):136-42. PubMed ID: 2966477
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporine A treatment induces changes in CD45R (restricted common leukocyte antigen) expression in the mixed lymphocyte reaction.
    Stein-Oakley AN; Kraft NE; Hutchinson P; Thomson NM
    Transplant Proc; 1989 Oct; 21(5):3759-60. PubMed ID: 2530675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.